Page 7 - Adicet Bio News Today

Adicet Bio Stock (NASDAQ: ACET) stock price, news, charts, stock research, profile.

Shares of Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) have earned an average rating of “Moderate Buy” from the six brokerages that are presently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month price […]

Wedbush reissued their outperform rating on shares of Adicet Bio (NASDAQ:ACET – Free Report) in a report released on Thursday, Benzinga reports. The firm currently has a $17.00 target price on the stock. A number of other analysts have also weighed in on the company. JPMorgan Chase & Co. lowered Adicet Bio from an overweight […]

Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) saw a significant drop in short interest in July. As of July 31st, there was short interest totalling 2,300,000 shares, a drop of 22.3% from the July 15th total of 2,960,000 shares. Based on an average daily volume of 875,300 shares, the days-to-cover ratio is presently 2.6 […]

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Announced encouraging safety and efficacy data in ongoing Phase 1 study of ADI-001 for the potential treatment of relapsed or refractory B-cell non-Hodgkin’s lymphoma (NHL)On track to report a clinical update for ADI-001 in second half of 2024Plan to file Investigational New Drug Application (IND) for ADI-925 in H2...

/PRNewswire/ -- The "Allogeneic Cell Therapy: Global Market Report 2023-2035" report has been added to ResearchAndMarkets.coms offering. The global allogeneic...

Announced encouraging safety and efficacy data in ongoing Phase 1 study of ADI-001 for the potential treatment of relapsed or refractory B-cell non-Hodgkin’s lymphoma On track to report a...

Adicet Bio (NASDAQ:ACET – Get Free Report) is scheduled to announce its earnings results on Tuesday, August 8th. Adicet Bio (NASDAQ:ACET – Get Free Report) last announced its quarterly earnings data on Tuesday, May 9th. The company reported ($0.72) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.74) by $0.02. On […]

Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) was the recipient of a significant decrease in short interest during the month of July. As of July 15th, there was short interest totalling 2,960,000 shares, a decrease of 5.7% from the June 30th total of 3,140,000 shares. Based on an average trading volume of 835,400 shares, […]